Peter Bialek

Peter Bialek

Company: Triplet Therapeutics

Job title: Head of Translational Biology

Seminars:

Panel Discussion: Navigating Rare Disease Drug Development Regulation Pathways 12:30 pm

• With regulatory paths there is not a ‘one size fits all’ approach in rare disease, how can current pathways guide study planning across indications? • What expertise is needed to plan for regulatory filing? • How can CDx planning begin earlier when required for drug approval?Read more

day: Day Two

Using Longitudinal Data to Understand How a Biomarker Behaves 10:00 am

• Design and execution of a natural history study to obtain a more holistic picture of disease • Avoiding bias, by investigating possible prognostic, stratification, disease relevant biomarkers as part of a study • Measuring target engagement in accessible biofluids, particularly using information from CSF exosomes, to collect evidence for pharmacological effectRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.